Meaningful strength improvements. Lasting results.

ANEUVO is committed to helping people with spinal cord injuries (SCI) live better through the ExaStim® Stimulation System, a revolutionary new therapeutic device that helps improve hand sensation and strength. ExaStim has been demonstrated safe and effective and is approved for use in clinic and home.

Wavelengths
Wavelengths

Healthcare Professionals

Real functional improvement. Real-life benefits.

Explore new possibilities in therapy with ANEUVO’s Exastim, an easy-to-use, non-invasive neurostimulation device. Patients in a recent clinical study with chronic, traumatic spinal cord injuries who received ExaStim therapy demonstrated more than a 2x greater functional improvement than those who did not receive ExaStim therapy.

*Results from the ASPIRE Study.

Learn More

Explore new possibilities in therapy with ANEUVO's ExaStim.

Patients & Caregivers

Move toward a stronger you.

Move toward accomplishing your therapy goals with ANEUVO ExaStim, a portable, non-surgical neurostimulation device designed to help improve hand sensation and strength. ExaStim moves with you—from clinic to home—making it easier to move your goals forward.

Learn More

Move toward accomplishing your therapy goals with ANEUVO's ExaStim.

Technology

Pioneering technology. Promising results.

ANEUVO is focused on treating disabling injuries and conditions that have not been curable through traditional pharmaceutical approaches. Our innovative ExaStim Stimulation System has received CE Mark approval in Europe and FDA clearance in the United States. When used in combination with rehabilitation, ExaStim helps patients to recover lost hand sensation, and strength, for better quality of life.

Understanding the Science Behind ExaStim® Technology

The brain sends and receives nerve signals that control movement—and the spinal cord carries these signals from the brain to the rest of the body. Spinal cord injuries can damage nerve fibers, causing changes in feeling, movement, strength, and body function.

Learn More

A Non-Invasive Approach to Neuromodulation

ExaStim provides therapy without the risks and complications of surgery. As a non-invasive device, it delivers spinal stimulation via 16 electrodes on a flexible pad that adheres to the skin and moves with the body.

Learn More

Advanced technology. Simple usability.

ExaStim is easy to use. Clinicians control therapy through an intuitive, app-based platform on a familiar touchscreen tablet. Lightweight, portable, and rechargeable, ExaStim provides convenient, accessible therapy from any location.

Learn More

Science

Approach

Application

The Company

At ANEUVO, we share a common goal: to help restore functional independence, improve quality of life, and create a healthier, more equitable world for people living with disabling diseases and conditions.

Learn More

Support for clinicians.
Peace of mind for their patients.

Contact Us

ANEUVO in the News

ANEUVO has been featured by leading news networks, business and health podcasts, and science and research conferences around the world. Learn more about our company, our technology, and individuals’ experiences with transcutaneous spinal stimulation and the ExaStim Stimulation System in the stories below.

Content Categories

ANEUVO Receives FDA Clearance for ExaStim<sup><sup>®</sup></sup>

ANEUVO Receives FDA Clearance for ExaStim®

U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...

Read more
ANEUVO Receives FDA Clearance for ExaStim<sup><sup>®</sup></sup>

ANEUVO Receives FDA Clearance for ExaStim®

U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...

Read more
Investigational therapy helps Easthampton man regain movement after spinal cord injury

Investigational therapy helps Easthampton man regain movement after spinal cord injury

EASTHAMPTON, MA (WGGB/WSHM) -- Nearly a decade after a training ride crash left him with a spinal cord injury, an Easthampton man is regaining function...

Read more
ANEUVO Secures Series C Funding to Strengthen ExaStim<sup>®</sup> Regulatory Readiness and Global Operational Scale

ANEUVO Secures Series C Funding to Strengthen ExaStim® Regulatory Readiness and Global Operational Scale

Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company...

Read more
ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim<sup>®</sup> Neuromodulation Technology

ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology

Honor highlights international startup advancing non-invasive rehabilitation technology for people living with chronic spinal cord injury Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) --...

Read more
ANEUVO Showcases ExaStim<sup>®</sup> Therapy At RehaCare 2025 and ISCoS 2025

ANEUVO Showcases ExaStim® Therapy At RehaCare 2025 and ISCoS 2025

The first MDR-Approved Non-Invasive Spinal Stimulation System in Europe Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two...

Read more
ANEUVO’s ExaStim<sup>®</sup> Earns CE Mark Certification

ANEUVO’s ExaStim® Earns CE Mark Certification

Key Milestone Signals Readiness for European Market Entry and Commitment to Quality Los Angeles, CA, April 09, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a pioneer in...

Read more
ANEUVO Launches ASPIRE<sup>™</sup> Home Study to Evaluate Home Use of ExaStim<sup>®</sup>

ANEUVO Launches ASPIRE™ Home Study to Evaluate Home Use of ExaStim®

This new phase of clinical research will test the safety and feasibility of ANEUVO’s non-invasive therapy for future use by individuals living with chronic spinal...

Read more
View More